
Linus Health: Revolutionizing mental and brain health through advanced digital biomarkers.
Linus Health, founded with a mission to revolutionize mental and brain health, leverages advanced digital biomarkers and phenotyping to empower individuals, patients, clinicians, caregivers, and researchers. The company offers a next-generation digital cognitive assessment platform designed for the early detection and intervention of Alzheimer's and other dementias. Linus Health focuses on addressing the rising urgency for innovation in cognitive care, aiming to mitigate the projected increase in global dementia cases.
Notable affiliated individuals include experts in neurology and digital health, contributing to the company's robust scientific foundation. Key investors have supported Linus Health in its mission to transform cognitive care. The company has achieved significant milestones in developing tools that enable earlier detection of cognitive decline, thereby potentially improving patient outcomes and reducing the burden on healthcare systems. Linus Health's impact is marked by its commitment to advancing early intervention strategies in brain health.

Linus Biotechnology
linusbio.com

Mios Health

CognitiveCare
cognitivecare.com

Neurotrack
neurotrack.com

n1 Health
n1health.com

HealthRhythms
healthrhythms.com

Viewmind

Mindflow Health

CogniFit
cognifit.com

NeuroVision Imaging
neurovision.com

Cogniant.co
cogniant.co

Isaac Health
myisaachealth.com

NewTouch Digital

Spring Health
springhealth.com
RC21X
rc21x.com
Companies similar to Linus Health include Linus Biotechnology, Mios Health, CognitiveCare and Neurotrack.
Linus Health was founded in 2019.
Linus Health's headquarters is located in Boston, MA, US.
Linus Health's most recent funding round was for $55M (USD) in July 2021.
As of Jul 6, 2021, Linus Health has raised a total of $64.9M (USD).
Linus Health has 23 employees as of Feb 5, 2024.